The main goal of this clinical trial is to use a novel exercise intervention to improve cardiometabolic and biopsychosocial health outcomes in overweight/obese sedentary survivors of AYA cancers at risk for chronic comorbid conditions. The investigator's hypothesis is that an exercise intervention will improve: cardiometabolic health; body composition; physical fitness and biopsychosocial outcomes when compared to the attention control group.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
personalized exercise prescription
Cardiometabolic health - Insulin Resistance
insulin resistance estimated by HOMA from a fasting blood sample
Time frame: change from baseline to 4 months, to 8 months to 1 year
Cardiometabolic health - metabolic syndrome waist circumference
markers of metabolic syndrome, waist circumference via measuring tape (cm)
Time frame: change from baseline to 4 months, to 8 months to 1 year
Cardiometabolic health - metabolic syndrome blood pressure
markers of metabolic syndrome, blood pressure via Omron cuff (mmHg)
Time frame: change from baseline to 4 months, to 8 months to 1 year
Body Composition
fat mass and lean mass via DEXA (reported in lbs)
Time frame: change from baseline to 4 months, to 8 months to 1 year
Cardiorespiratory fitness (Physical Fitness)
cardiorespiratory fitness via submaximal VO2 max (reported via ml/kg/min)
Time frame: change from baseline to 4 months, to 8 months to 1 year
Muscular Strength (Physical Fitness)
muscle strength through multiple repetition maximum (lbs)
Time frame: change from baseline to 4 months, to 8 months to 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.